Clinical trial
ADaptiVe Biomarker Trial That InformS Evolution of Therapy
NCT03335540 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ADaptiVe Biomarker Trial That InformS Evolution of Therapy
- Lead sponsor
- Bristol-Myers Squibb
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 7, 2018
- Completion date
- August 25, 2021
- Enrollment
- 20 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
advanced cancer